Cisplatin and its analogues, that is, agents which play a highly significant role in the management of ovarian cancer, have been proven to present a risk factor for ovarian failure by an estimated odds ratio as high as 1.77 [ 28 ].
← all excerpts
Fertility-sparing surgery in early epithelial ovarian cancer: a viable option?
1
—
—